Glenmark becomes the first company in India to launch Thiazolidinedione Lobeglitazone (0.5 mg) in India for Uncontrolled Type 2 Diabetes in Adults
This anti-diabetic medication will be marketed under brand name LOBG. With this launch, the company aims to improve glycemic levels in uncontrolled diabetics and create a new pathway to treat insulin resistance in India. Glenmark’s…